Evidence method
Level · gp.fundamentals.capex_revenue_ratio
15.88% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Dec 31, 2015
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-16-012682General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
652.99% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
50.00% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
474.46% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
-452.02% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
123.51% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
427.52% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
69.17% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.44%
- Current
- 15.88%
- Delta
- 15.45%
- Previous
- 6.16%
- Current
- 652.99%
- Delta
- 646.83%
- Previous
- -18.95%
- Current
- 50.00%
- Delta
- 68.95%
- Previous
- 53.34%
- Current
- 474.46%
- Delta
- 421.12%
- Previous
- 87.57%
- Current
- -452.02%
- Delta
- -539.59%
- Previous
- 3.44%
- Current
- 123.51%
- Delta
- 120.08%
- Previous
- 9.61%
- Current
- 427.52%
- Delta
- 417.91%
- Previous
- -1.56%
- Current
- 69.17%
- Delta
- 70.73%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_INCREASED →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_DECREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.